All Stories

New York, Assurex Health announced today that it has secured $15 million in equity financing from Series D investors. Investors included existing shareholders Sequoia Capital, Claremont Creek Ventures, Cincinnati Children’s Hospital Medical Center, Mayo Clinic, and Cross Creek Advisors, among…

Navitor Pharmaceuticals, Inc., a Cambridge, MA-based biopharmaceutical company developing novel medicines targeting the activation of mTORC1*, completed a $33m Series B financing. he round was led by new investor Brace Pharma Capital, LLC, a strategic investment company formed by EMS…

Baltimore, Maryland-based WellDoc has raised $22 million in a round. Samsung Ventures acted as the lead investor in the round with existing investor Merck Global Health Innovation Fund serving as co-lead. Adage Capital Management, Excel Venture Management, Alexandria Venture Investments…

Gelesis, a Boston, MA-based clinical stage biotechnology company focused on the development of products to safely induce weight loss and improve glycemic control, closed a $31.5m growth financing round. Backers included Cormorant Asset Management, and current investors Invesco Asset Management,…